Concurrent Investment Advisors LLC raised its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 148.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,879 shares of the real estate investment trust's stock after buying an additional 16,661 shares during the period. Concurrent Investment Advisors LLC's holdings in Healthpeak Properties were worth $488,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Healthpeak Properties by 584.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock valued at $186,405,000 after purchasing an additional 7,872,150 shares in the last quarter. Nuveen LLC purchased a new stake in Healthpeak Properties during the first quarter worth $124,113,000. Invesco Ltd. grew its holdings in Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Healthpeak Properties by 57.8% in the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock valued at $136,785,000 after buying an additional 2,477,307 shares in the last quarter. Finally, Amundi increased its position in shares of Healthpeak Properties by 89.4% in the first quarter. Amundi now owns 5,047,699 shares of the real estate investment trust's stock valued at $98,228,000 after buying an additional 2,382,657 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.
Insider Transactions at Healthpeak Properties
In related news, CEO Scott M. Brinker purchased 1,490 shares of the company's stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the transaction, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have purchased 8,783 shares of company stock valued at $150,129 in the last ninety days. 0.23% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on DOC shares. Weiss Ratings reiterated a "hold (c-)" rating on shares of Healthpeak Properties in a research report on Wednesday, October 8th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 27th. Morgan Stanley dropped their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Evercore ISI set a $22.00 target price on Healthpeak Properties in a research note on Monday, September 15th. Finally, Cantor Fitzgerald initiated coverage on Healthpeak Properties in a report on Wednesday, October 1st. They set a "neutral" rating and a $20.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $21.33.
Get Our Latest Analysis on DOC
Healthpeak Properties Trading Up 0.5%
Shares of Healthpeak Properties stock opened at $18.55 on Friday. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26. The business's fifty day moving average is $18.16 and its two-hundred day moving average is $17.90. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market cap of $12.89 billion, a PE ratio of 77.27, a P/E/G ratio of 3.16 and a beta of 1.09.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same period in the prior year, the firm posted $0.45 earnings per share. The business's quarterly revenue was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) annualized dividend and a dividend yield of 6.6%. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.